sees qtr-two adjusted earnings per share $num-three to $num - four from continuing operations.
sees fy adjusted earnings per share $num-one to $num - two.
qtr-one adjusted earnings per share $num-one.
sees qtr-three sales $num-one billion to $1.num-two billion.
qtr-three sales rose num-two percent to $num-one billion.
qtrly total sales grew num-one% year-over-year on an underlying basis.
qtr-one sales rose num-two percent to $num-one million.
qtr-one sales $num-one million versus refinitiv ibes estimate of $4.32 billion.
qtr-one sales rose num-two percent to $num-one million.
sees fy year-six average diluted shares outstanding to be between num-one million and num-two million.
qtrly underlying tavr sales grew num-one% to num-two% year-six.
compname announces num-one million vaccinations performed in qtr-three.
qtr-two earnings per share $num-one.
sees fy sales $num-one million.
sees year-six surgical structural heart market will grow in mid-single digits through num-two percent.
qtr-one earnings per share $num-one.
